Mmastodon BusinessBusiness first seen 2 d ago, last 1 d ago, peak #2

Stryker invests $400m in CMR Surgical for US rights to Versius

Original: Stryker has agreed to invest about $400m in CMR Surgical and secure exclusive US sales rights for Versius, strengthening

Stryker has agreed to invest roughly $400m in UK-based CMR Surgical and secured exclusive US sales rights for its Versius surgical robot, strengthening its challenge to Intuitive Surgical's dominant da Vinci system. Versius' modular design, using separate robotic arm carts that teams can arrange around the operating table, is seen as a key differentiator as the two companies compete in soft-tissue robotic surgery.

Why now: The deal reshapes the competitive landscape in robotic surgery, directly challenging Intuitive's long-held dominance in the US market.

StrykerCMR SurgicalVersiusIntuitive Surgical

Open on mastodon →

Evidence

• Stryker has agreed to invest about $400m in CMR Surgical and secure exclusive US sales rights for Versius, strengthening its position against Intuitive’s da Vinci. One of Versius' key strengths is modular design: it uses separate robotic arm carts that teams can arrange around… · MoveTheNeedle@masto.nu · 3

API: https://socialmediatrends-api.osmike.com/v1/trends/2232205